{
    "Trade/Device Name(s)": [
        "VENTANA CD30 (Ber-H2) Assay"
    ],
    "Submitter Information": "Ventana Medical Systems, Inc.",
    "510(k) Number": "K172471",
    "Predicate Device Reference 510(k) Number(s)": [
        "K965022"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DEH"
    ],
    "Summary Letter Date": "April 5, 2018",
    "Summary Letter Received Date": "April 6, 2018",
    "Submission Date": "May 4, 2018",
    "Regulation Number(s)": [
        "21CFR866.5550"
    ],
    "Regulation Name(s)": [
        "Immunoglobulin (light chain specific) immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "anatomic pathology"
    ],
    "Analyte(s)": [
        "CD30"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded tissue"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VENTANA BenchMark ULTRA instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Immunohistochemistry (IHC)",
        "Horseradish peroxidase enzymatic reaction"
    ],
    "Methodologies": [
        "Indirect, biotin-free detection",
        "Bright-field microscopy"
    ],
    "Submission Type(s)": [
        "Assay",
        "Antibody",
        "Reagent",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for VENTANA CD30 (Ber-H2) Assay using immunohistochemistry for detection of CD30 in formalin-fixed, paraffin-embedded tissue.",
    "Indications for Use Summary": "Qualitative detection of CD30 protein in formalin-fixed, paraffin-embedded tissue stained with a VENTANA BenchMark ULTRA instrument to aid in identifying classical Hodgkin lymphoma, anaplastic large cell lymphoma, and cutaneous T-cell lymphoma, interpreted by a qualified pathologist in conjunction with histological examination and clinical information.",
    "fda_folder": "Immunology"
}